FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB1 day ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
FTC Releases Interim Staff Report on Prescription Drug Middlemen
WEBThe Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
FTC sues pharmacy benefit managers for inflating price of insulin …
WEB18 hours ago · The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin.
Pharmacy Benefit Managers: The Powerful Middlemen Inflating …
WEBJul 9, 2024 · Visit the Noncompetes feature page for more information, including factsheets featuring stories on how the rule can benefit Americans.
Federal Trade Commission sues largest drug middlemen for
WEB1 day ago · CNN —. The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
Federal Trade Commission accuses three drug middlemen of …
WEB1 day ago · The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices. The FTC accused the "Big Three" pharmacy benefit managers (PBMs ...
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
WEBJul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating...
FTC Sues Pharmacy Benefit Managers for Inflating Insulin Prices
WEB2 days ago · Today, the Federal Trade Commission (FTC) announced that the organization filed legal action against the country’s three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts and OptumRx—for engaging in anti-competitive and unfair practices that inflated the price of insulin drugs, blocked patients’ access to more affordable products and shifted the cost of ...
Pharmacy benefit managers profit at expense of patients and small ... - CNN
WEBJul 9, 2024 · CNN — Pharmacy benefit managers, which negotiate the terms for prescription drug access for hundreds of millions of Americans, are racking up profits while squeezing patients and independent...
FTC sues insulin middlemen, saying they pocket ... - Health News …
WEB18 hours ago · In a new lawsuit filed Friday, the Federal Trade Commission said it's going after one link in the chain: pharmacy benefit managers (PBMs). The FTC brought action against the top PBMs — CVS Health's Caremark Rx, Cigna's Express Scripts, and United Health Group's OptumRx — saying the companies created a …
Skip to content